Agency Information Collection Activities Under Emergency Review by the Office of Management and Budget, 85584-85585 [2016-28569]
Download as PDF
<![CDATA[
85584
Federal Register / Vol. 81, No. 228 / Monday, November 28, 2016 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Psychiatric Disorders and
Addiction.
Date: December 13, 2016.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Samuel C Edwards, Ph.D.,
IRG Chief, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5210, MSC 7846, Bethesda, MD
20892, (301) 435–1246, edwardss@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Neurovirology, Neuroimmunology,
Neurodevelopmental Disorders, and
Anticancer Drugs.
Date: December 15, 2016.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Samuel C. Edwards, Ph.D.,
IRG Chief, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5210, MSC 7846, Bethesda, MD
20892, (301) 435–1246, edwardss@
csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 21, 2016.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–28415 Filed 11–25–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities Under Emergency Review by
the Office of Management and Budget
The Substance Abuse and Mental
Health Services Administration
(SAMHSA) has submitted the following
request (see below) for emergency OMB
review under the Paperwork Reduction
Act (44 U.S.C. Chapter 35). OMB
approval has been requested by January
12, 2017. A copy of the information
collection plans may be obtained by
calling the SAMHSA Reports Clearance
Officer at (240) 276–1243.
Title: Notification of Intent to Use
Schedule III, IV, or V Opioid Drugs for
the Maintenance and Detoxification
Treatment of Opiate Addiction by a
‘‘Qualifying Other Practitioner’’—NEW.
OMB Number: 0930—New.
Frequency: On Going.
Affected public: Nurse Practitioners
and Physician Assistants.
The Substance Abuse and Mental
Health Services Administration
(SAMHSA) is requesting an emergency
Office of Management and Budget
(OMB) review and approval of the
Notification of Intent to Use Schedule
III, IV, or V Opioid Drugs for the
Number of
respondents
mstockstill on DSK3G9T082PROD with NOTICES
Purpose of submission
Notification of Intent for Qualifying Other Practitioner to Use Schedule III,
IV, or V Opioid Drugs for the Maintenance and Detoxification Treatment
of Opiate Addiction by a ‘‘Qualifying Other Practitioner’’ under 21 USC
§ 823(g)(2)—Nurse Practitioners ..................................................................
Notification of Intent for Qualifying Other Practitioner to Use Schedule III,
IV, or V Opioid Drugs for the Maintenance and Detoxification Treatment
of Opiate Addiction by a ‘‘Qualifying Other Practitioner’’ under 21 USC
§ 823(g)(2)—Physician Assistants ...............................................................
Total ..........................................................................................................
VerDate Sep<11>2014
21:15 Nov 25, 2016
Jkt 241001
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
Maintenance and Detoxification
Treatment of Opiate Addiction by a
‘‘Qualifying Other Practitioner. The
Notification of Intent would allow
SAMHSA to determine whether other
practitioners are eligible to prescribe
certain approved narcotic treatment
medications for the maintenance or
detoxification treatment of opioid
addiction.
This Notification of Intent is a result
of the Comprehensive Addiction and
Recovery Act (Pub. L. 114–198), which
was signed into law on July 22, 2016.
The law establishes criteria for nurse
practitioners (NPs) and physician
assistants (PAs) to qualify for a waiver
to prescribe covered medications. To be
eligible for a waiver, the NP or PA must:
be licensed under State law to prescribe
schedule III, IV, or V medications for the
treatment of pain; fulfill qualification
requirements in the law for training and
experience; and fulfill qualification
requirements in the law for appropriate
supervision by a qualifying physician.
SAMHSA has the responsibility to
receive, review, approve, or deny waiver
requests.
Practitioners who meet the statutory
requirements will be eligible to
prescribe only those opioid treatment
medications that are controlled in
Schedules III, IV, or V, under the
Controlled Substance Act (CSA), that
are specifically approved by the Food
and Drug Administration (FDA) for the
treatment of opioid addiction, and are
not the subject of an ‘‘adverse
determination.’’ The only medications
that currently fulfill these requirements
are ones that contain the active
ingredient buprenorphine.
Given the severity of the opioid
epidemic, SAMHSA is requesting an
emergency OMB approval. Emergency
OMB approval will enable NPs and PAs
to dramatically increase access to
buprenorphine among individuals with
opioid use disorder.
The following table is the estimated
hour burden:
Responses/
respondent
Burden hours
Total burden
hours
816
1
.066
54
590
1
.066
39
1,406
........................
........................
93
E:\FR\FM\28NON1.SGM
28NON1
85585
Federal Register / Vol. 81, No. 228 / Monday, November 28, 2016 / Notices
Written comments and
recommendations concerning the
proposed information collection should
be sent by January 12, 2017 to the
SAMHSA Desk Officer at the Office of
Information and Regulatory Affairs,
OMB. To ensure timely receipt of
comments, and to avoid potential delays
in OMB’s receipt and processing of mail
sent through the U.S. Postal Service,
commenters are encouraged to submit
their comments to OMB via email to:
OIRA_Submission@omb.eop.gov.
Although commenters are encouraged to
send their comments via email,
commenters may also fax their
comments to: 202–395–5806.
Commenters may also mail them to:
Office of Management and Budget,
Office of Information and Regulatory
Affairs, New Executive Office Building,
Room 10102, Washington, DC 20503.
Summer King,
Statistician.
[FR Doc. 2016–28569 Filed 11–25–16; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Project: National Mental Health
Services Survey (N–MHSS) (OMB No.
0930–0119)—Revision
The Substance Abuse and Mental
Health Services Administration
(SAMHSA), Center for Behavioral
Health Statistics and Quality (CBHSQ)
is requesting a revision to the National
Mental Health Services Survey (N–
MHSS) (OMB No. 0930–0119), which
expires on February 28, 2017. The N–
MHSS provides annual national and
state-level data on the number and
characteristics of mental health
treatment facilities in the United States
and biennial national and state-level
data on the number and characteristics
of persons treated in these facilities.
The N–MHSS will provide updated
information about facilities for
SAMHSA’s online Behavioral Health
Treatment Services Locator (see: https://
findtreatment.samhsa.gov), which was
last updated with information from the
abbreviated N–MHSS (N–MHSS-Locator
Survey) in 2015. An abbreviated N–
MHSS (N–MHSS-Locator Survey) will
be conducted in 2017 and 2019 to
update the information about facilities
in the online Locator. A full-scale N–
MHSS will be conducted in 2018 to
collect (1) information about facilities
needed for updating the online Locator,
such as the facility name and address,
specific services offered, and special
client groups served and (2) additional
information about client counts and the
demographics of persons treated in
these facilities. Three small surveys are
proposed for adding new facilities to the
online Locator as they become known to
SAMHSA. Both the 2017 N–MHSSLocator Survey and the addition of new
facilities to the online Locator will use
the same N–MHSS-Locator Survey
instrument.
This request for a revision seeks to
change the content of the currently
approved abbreviated N–MHSS (i.e., N–
MHSS–Locator) survey instrument, and
the previously approved 2014 and 2016
full-scale N–MHSS (OMB No. 0930–
0119) to accommodate two related N–
MHSS activities:
(1) collection of information from the
total N–MHSS universe of mental health
treatment facilities during 2017, 2018,
and 2019; and
(2) collection of information on newly
identified facilities throughout the year
as they are identified so that new
facilities can quickly be added to the
online Locator.
The survey mode for both data
collection activities will be web with
telephone follow-up. A paper
questionnaire will also be available to
facilities who request one.
The database resulting from the N–
MHSS will be used to update
SAMHSA’s online Behavioral Health
Treatment Services Locator and to
produce an electronic version of a
national directory of mental health
facilities, for use by the general public,
behavioral health professionals, and
treatment service providers. In addition,
a data file derived from the survey will
be used to produce a summary report
providing national and state-level
outcomes. The summary report and a
public-use data file will be used by
researchers, mental health professionals,
State governments, the U.S. Congress,
and the general public.
The request for OMB approval will
include a request to conduct an
abbreviated N–MHSS-Locator survey in
2017 and 2019, and the full-scale N–
MHSS in 2018.
The following table summarizes the
estimated annual response burden for
the N–MHSS:
ESTIMATED ANNUAL RESPONSE BURDEN FOR THE N–MHSS
Number of
respondents
Type of respondent
Responses
per respondent
Average hours
per response
Total burden
hours
Facilities in N–MHSS-Locator Survey universe in 2017 and 2019 .................
Newly identified facilities in Between-Survey Update in 2017, 2018, and
2019 1 ...........................................................................................................
Facilities in full-scale N–MHSS universe in 2018 ............................................
17,000
1
0.42
7,140
1,700
17,000
1
1
0.42
0.75
714
12,750
Average Annual Total ...............................................................................
18,700
1
0.62
9,724
mstockstill on DSK3G9T082PROD with NOTICES
1 Collection
of information on newly identified facilities throughout the year, as they are identified, so that new facilities can quickly be added to
the Locator.
Written comments and
recommendations concerning the
proposed information collection should
be sent by December 28, 2016 to the
SAMHSA Desk Officer at the Office of
VerDate Sep<11>2014
21:15 Nov 25, 2016
Jkt 241001
Information and Regulatory Affairs,
Office of Management and Budget
(OMB). To ensure timely receipt of
comments, and to avoid potential delays
in OMB’s receipt and processing of mail
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
sent through the U.S. Postal Service,
commenters are encouraged to submit
their comments to OMB via email to:
OIRA_Submission@omb.eop.gov.
Although commenters are encouraged to
E:\FR\FM\28NON1.SGM
28NON1
]]>Agencies
[Federal Register Volume 81, Number 228 (Monday, November 28, 2016)]
[Notices]
[Pages 85584-85585]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-28569]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities Under Emergency Review
by the Office of Management and Budget
The Substance Abuse and Mental Health Services Administration
(SAMHSA) has submitted the following request (see below) for emergency
OMB review under the Paperwork Reduction Act (44 U.S.C. Chapter 35).
OMB approval has been requested by January 12, 2017. A copy of the
information collection plans may be obtained by calling the SAMHSA
Reports Clearance Officer at (240) 276-1243.
Title: Notification of Intent to Use Schedule III, IV, or V Opioid
Drugs for the Maintenance and Detoxification Treatment of Opiate
Addiction by a ``Qualifying Other Practitioner''--NEW.
OMB Number: 0930--New.
Frequency: On Going.
Affected public: Nurse Practitioners and Physician Assistants.
The Substance Abuse and Mental Health Services Administration
(SAMHSA) is requesting an emergency Office of Management and Budget
(OMB) review and approval of the Notification of Intent to Use Schedule
III, IV, or V Opioid Drugs for the Maintenance and Detoxification
Treatment of Opiate Addiction by a ``Qualifying Other Practitioner. The
Notification of Intent would allow SAMHSA to determine whether other
practitioners are eligible to prescribe certain approved narcotic
treatment medications for the maintenance or detoxification treatment
of opioid addiction.
This Notification of Intent is a result of the Comprehensive
Addiction and Recovery Act (Pub. L. 114-198), which was signed into law
on July 22, 2016. The law establishes criteria for nurse practitioners
(NPs) and physician assistants (PAs) to qualify for a waiver to
prescribe covered medications. To be eligible for a waiver, the NP or
PA must: be licensed under State law to prescribe schedule III, IV, or
V medications for the treatment of pain; fulfill qualification
requirements in the law for training and experience; and fulfill
qualification requirements in the law for appropriate supervision by a
qualifying physician. SAMHSA has the responsibility to receive, review,
approve, or deny waiver requests.
Practitioners who meet the statutory requirements will be eligible
to prescribe only those opioid treatment medications that are
controlled in Schedules III, IV, or V, under the Controlled Substance
Act (CSA), that are specifically approved by the Food and Drug
Administration (FDA) for the treatment of opioid addiction, and are not
the subject of an ``adverse determination.'' The only medications that
currently fulfill these requirements are ones that contain the active
ingredient buprenorphine.
Given the severity of the opioid epidemic, SAMHSA is requesting an
emergency OMB approval. Emergency OMB approval will enable NPs and PAs
to dramatically increase access to buprenorphine among individuals with
opioid use disorder.
The following table is the estimated hour burden:
----------------------------------------------------------------------------------------------------------------
Number of Responses/ Total burden
Purpose of submission respondents respondent Burden hours hours
----------------------------------------------------------------------------------------------------------------
Notification of Intent for Qualifying Other 816 1 .066 54
Practitioner to Use Schedule III, IV, or V
Opioid Drugs for the Maintenance and
Detoxification Treatment of Opiate Addiction by
a ``Qualifying Other Practitioner'' under 21
USC Sec. 823(g)(2)--Nurse Practitioners......
Notification of Intent for Qualifying Other 590 1 .066 39
Practitioner to Use Schedule III, IV, or V
Opioid Drugs for the Maintenance and
Detoxification Treatment of Opiate Addiction by
a ``Qualifying Other Practitioner'' under 21
USC Sec. 823(g)(2)--Physician Assistants.....
---------------------------------------------------------------
Total....................................... 1,406 .............. .............. 93
----------------------------------------------------------------------------------------------------------------
[[Page 85585]]
Written comments and recommendations concerning the proposed
information collection should be sent by January 12, 2017 to the SAMHSA
Desk Officer at the Office of Information and Regulatory Affairs, OMB.
To ensure timely receipt of comments, and to avoid potential delays in
OMB's receipt and processing of mail sent through the U.S. Postal
Service, commenters are encouraged to submit their comments to OMB via
email to: OIRA_Submission@omb.eop.gov. Although commenters are
encouraged to send their comments via email, commenters may also fax
their comments to: 202-395-5806. Commenters may also mail them to:
Office of Management and Budget, Office of Information and Regulatory
Affairs, New Executive Office Building, Room 10102, Washington, DC
20503.
Summer King,
Statistician.
[FR Doc. 2016-28569 Filed 11-25-16; 8:45 am]
BILLING CODE 4162-20-P
